Fund shareholders of NRX Therapeutics Inc
ISIN US6294442099 · United States · LEI 5493003FN4CLS0670T77
- Fund shareholders
- 11
- Of which ETFs
- 2 9 other funds
- Value held
- 3.9M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 744,532 | 1.6M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 420,467 | 895.6K $ | 4.42 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 324,194 | 690.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 108,992 | 202.7K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 66,109 | 140.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 62,612 | 133.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 30,812 | 57.3K $ | as of Feb 28, 2026 ↗ | |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 28,846 | 61.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 25,206 | 46.9K $ | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 21,976 | 40.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 4,246 | 9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.42 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 11 | 0 | 1,837,992 | +57.4 % |
| 2026Q1 | 11 | 0 | 1,167,528 | +21.2 % |
| 2025Q4 | 11 | +2 | 963,591 | +11.4 % |
| 2025Q3 | 9 | +3 | 865,259 | +15.8 % |
| 2025Q2 | 6 | 0 | 747,520 | +21.7 % |
| 2025Q1 | 6 | -1 | 614,187 | +42.2 % |
| 2024Q4 | 7 | -1 | 432,051 | +8.7 % |
| 2024Q3 | 8 | +7 | 397,371 | +8,984.8 % |
| 2024Q2 | 1 | 4,374 |
Institutional managers
29 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| B Group, Inc. | 3,000,000 | 6.4M $ | as of Mar 31, 2026 |
| AdvisorShares Investments LLC | 420,467 | 895.6K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 397,431 | 846.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 310,112 | 660.6K $ | as of Mar 31, 2026 |
| Bleakley Financial Group, LLC | 117,204 | 249.6K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 98,995 | 210.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 86,984 | 185.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 78,733 | 167.7K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 44,152 | 94K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 43,469 | 92.6K $ | as of Mar 31, 2026 |
| Headlands Technologies LLC | 39,394 | 83.9K $ | as of Mar 31, 2026 |
| Chicago Partners Investment Group LLC | 34,479 | 102.4K $ | as of Mar 31, 2026 |
| AXQ CAPITAL, LP | 33,211 | 70.7K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 31,785 | 68 $ | as of Mar 31, 2026 |
| UBS Group AG | 25,227 | 53.7K $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 19,876 | 42.3K $ | as of Mar 31, 2026 |
| Ethos Financial Group, LLC | 15,900 | 33.9K $ | as of Mar 31, 2026 |
| SJBENEN ADVISORY, LLC | 15,000 | 32K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 10,028 | 21.4K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 2,509 | 5K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 2,500 | 5.3K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 2,350 | 5K $ | as of Mar 31, 2026 |
| SUMMIT SECURITIES GROUP LLC | 1,135 | 2.4K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 737 | 1.6K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 90 | 191 $ | as of Mar 31, 2026 |
Declared shareholders of NRX Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Anson Funds Management LP and 5 others | 4.90 % | 1,736,737 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of NRX Therapeutics Inc". https://titelia.com/en/stocks/nrx-therapeutics-inc-US6294442099